CRISPR/dCas9 for hepatic fibrosis therapy: implications and challenges
- 12 August 2022
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 49 (12) , 11403-11408
Abstract
Hepatic fibrosis is a pathological reaction of tissue damage and repair caused by various pathogenic factors acting on liver. At present, there is no effective anti-fibrotic specific therapy. Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (dCas9) system is a new generation of gene editing technology. The CRISPR/dCas9 system provides a platform for studying site-specific transcriptional regulation, which has high efficiency in gene transcriptional activation for achieving robust. This system holds promise for hepatic fibrosis therapy via acting on liver fibrosis effector cells. However, there are some challenges associated with this novel technology, such as large structural variants at on-target, off-target sites, and targeted delivery efficiency. In this review, we present the potential implications and describe the challenges of CRISPR/dCas9 system that might be encountered in hepatic fibrosis therapy.Keywords
Funding Information
- Shaanxi Social Development Fund (2020SF-067)
This publication has 61 references indexed in Scilit:
- Efficient In Vivo Liver-Directed Gene Editing Using CRISPR/Cas9Molecular Therapy, 2018
- Engineering the Delivery System for CRISPR-Based Genome EditingTrends in Biotechnology, 2018
- Exosome–Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCsAdvanced Science, 2018
- FOXA2 alleviates CCl4-induced liver fibrosis by protecting hepatocytes in miceScientific Reports, 2017
- Younger trend of cirrhosis incidence in genotype 3 HCV infected patients in Eastern ChinaJournal of Medical Virology, 2017
- Highly efficient Cas9-mediated transcriptional programmingNature Methods, 2015
- Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complexNature, 2014
- CRISPR RNA–guided activation of endogenous human genesNature Methods, 2013
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013
- Hepatocyte nuclear factor 4α attenuates hepatic fibrosis in ratsGut, 2009